C. Tissing-Tan

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.

D. de Ruysscher, E. Smit, D. Ruysscher, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MA 17.10 Toxicity Results from the Randomized Phase III NVALT-11 Study of Prophylactic Cranial Irradiation vs. Observation in Stage III NSCLC

H. Groen, E. Smit, A. Dingemans, 2017 .

Prophylactic cranial irradiation (PCI) versus observation in radically treated stage III non-small cell lung cancer (NSCLC): A randomized phase III NVALT11 study.

H. Groen, E. Smit, A. Dingemans, 2017 .

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial

V. Remouchamps, C. Faivre-Finn, F. Blackhall, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.

V. Remouchamps, C. Faivre-Finn, F. Blackhall, 2017 .

External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.

L. de Geus-Oei, J. Bussink, R. Monshouwer, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis

S. Senan, W. Verbakel, M. Dahele, 2021, JTO clinical and research reports.

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.

Bingshu E. Chen, M. Brundage, Y. M. van der Linden, 2014, The Lancet. Oncology.

Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.

Bingshu E. Chen, M. Brundage, Y. M. van der Linden, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.

H. Groen, D. de Ruysscher, E. Smit, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Determinants of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients

J. Bussink, J. Belderbos, J. Widder, 2015 .

The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.

E. Dieleman, N. C. van der Voort van Zyp, J. Pomp, 2022, Clinical lung cancer.